| 10/07/24 | 16:24:22 | 10 Jul 2024 | | Holding(s) in Company | RNS |
| 10/07/24 | 08:10:00 | 10 Jul 2024 | | Admission & Director/PDMR Shareholding | RNS |
| 03/07/24 | 14:29:19 | 3 Jul 2024 | | Publication of a Prospectus | RNS |
| 28/06/24 | 12:58:54 | 28 Jun 2024 | | Result of AGM | RNS |
| 07/06/24 | 07:00:08 | 7 Jun 2024 | | Business Update | RNS |
| 04/06/24 | 16:26:23 | 4 Jun 2024 | | Notice of AGM | RNS |
| 31/05/24 | 07:00:05 | 31 May 2024 | | Patent Application | RNS |
| 28/05/24 | 07:00:15 | 28 May 2024 | | Regulatory Application | RNS |
| 09/05/24 | 07:00:08 | 9 May 2024 | | Update on recent developments | RNS |
| 07/05/24 | 07:00:12 | 7 May 2024 | | Grant of Haemostatic Hydrogel Patent | RNS |
| 03/05/24 | 07:00:09 | 3 May 2024 | | Divestment of Graft Polymer d.o.o – Slo facility | RNS |
| 02/05/24 | 07:00:10 | 2 May 2024 | | Replacement of Chief Executive Officer | RNS |
| 30/04/24 | 17:05:39 | 30 Apr 2024 | | Annual Financial Report | RNS |
| 23/04/24 | 16:17:52 | 23 Apr 2024 | | Loan facility update | RNS |
| 15/03/24 | 07:00:09 | 15 Mar 2024 | | Chairman & Directorate Change & Financial Update | RNS |
| 08/01/24 | 17:00:01 | 8 Jan 2024 | | Holding(s) in Company | RNS |
| 08/01/24 | 17:00:01 | 8 Jan 2024 | | GM Statement | RNS |
| 08/01/24 | 17:00:01 | 8 Jan 2024 | | Holding(s) in Company | RNS |
| 08/01/24 | 17:00:01 | 8 Jan 2024 | | Holding(s) in Company | RNS |
| 08/01/24 | 17:00:01 | 8 Jan 2024 | | Holding(s) in Company | RNS |
| 08/01/24 | 17:00:01 | 8 Jan 2024 | | Holding(s) in Company | RNS |
| 08/01/24 | 17:00:01 | 8 Jan 2024 | | Director/PDMR Shareholding | RNS |
| 27/12/23 | 07:00:04 | 27 Dec 2023 | | GM Notice 8th January 2024 | RNS |
| 22/12/23 | 07:00:04 | 22 Dec 2023 | | Placing of New Ordinary Shares | RNS |
| 09/10/23 | 07:00:14 | 9 Oct 2023 | | Pivotal Agreement within European Consortium | RNS |
| 27/09/23 | 07:02:01 | 27 Sept 2023 | | Updated Investor Presentation | RNS |
| 27/09/23 | 07:00:03 | 27 Sept 2023 | | Interim Financial Results | RNS |
| 11/09/23 | 07:00:04 | 11 Sept 2023 | | R&D Agreement with Slovenian Faculty | RNS |
| 04/09/23 | 07:00:04 | 4 Sept 2023 | | R&D and supply agreement with FORPET BALTIC | RNS |
| 30/08/23 | 07:00:05 | 30 Aug 2023 | | R&D Supply Agreement Signed | RNS |
| 23/08/23 | 07:00:05 | 23 Aug 2023 | | Graft Bio signs manufacturing services agreement | RNS |
| 27/07/23 | 11:54:55 | 27 Jul 2023 | | Result of AGM | RNS |
| 26/07/23 | 07:00:03 | 26 Jul 2023 | | Distribution agreement with US Inter-Technologies | RNS |
| 06/07/23 | 07:00:08 | 6 Jul 2023 | | New R&D and Supply Agreement with Gabriel Chemie | RNS |
| 05/07/23 | 07:00:03 | 5 Jul 2023 | | Operational Update | RNS |
| 04/07/23 | 07:00:06 | 4 Jul 2023 | | AGM Notice | RNS |
| 16/05/23 | 14:08:55 | 16 May 2023 | | Director Share Purchase | RNS |
| 27/04/23 | 07:00:07 | 27 Apr 2023 | | Final Results | RNS |
| 21/03/23 | 07:00:05 | 21 Mar 2023 | | GraftBio - MGC Pharma Update | RNS |
| 20/03/23 | 07:00:08 | 20 Mar 2023 | | Corporate Presentation | RNS |
| 09/02/23 | 07:00:08 | 9 Feb 2023 | | Update: New Product Lines & Facility Expansion | RNS |
| 30/09/22 | 07:00:13 | 30 Sept 2022 | | Interim Results | RNS |
| 20/09/22 | 07:00:14 | 20 Sept 2022 | | New Corporate Presentation | RNS |
| 18/08/22 | 10:00:07 | 18 Aug 2022 | | First Commercial Purchase Order for GraftBio | RNS |
| 28/07/22 | 12:30:05 | 28 Jul 2022 | | Result of AGM | RNS |
| 04/07/22 | 16:50:06 | 4 Jul 2022 | | Notice of AGM | RNS |
| 29/06/22 | 07:00:09 | 29 Jun 2022 | | Final Results | RNS |
| 20/06/22 | 07:00:05 | 20 Jun 2022 | | Operational Update | RNS |
| 17/06/22 | 07:00:06 | 17 Jun 2022 | | GraftBio IP – MGC Pharma Update | RNS |
| 18/05/22 | 07:00:11 | 18 May 2022 | | Director Share Purchase | RNS |
